← Back to headlines
Pfizer's Potential Monthly Weight Loss Shot to Challenge GLP-1 Duopoly
Pfizer is exploring a monthly weight loss shot that could potentially disrupt the current GLP-1 market, currently dominated by Lilly and Novo Nordisk.
21 Apr, 11:50 — 21 Apr, 11:50
Sources
Showing 1 of 1 sources
